DGAP-News: MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER
(firmenpresse) - DGAP-News: MIV Therapeutics Inc. / Key word(s): Change of Personnel
MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER
05.06.2013 / 16:07
---------------------------------------------------------------------
MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER
May 18th, 2013 MIV Therapeutics, Inc. (the 'Company' or 'MIV') announced
today that MIV accept the resignation of Mr. Chris Chen as director and
officer while welcome its new leader, Chairman&CEO Mr. XIAO.
Mr. XIAO says, ' Even though the company has experience lots of turmoil for
the last few years but I do have the confidence to move it forward. We are
currently working with a medical fund to be our strategic partner so as to
initiate the CE Marking application. It's time now to reveal the real value
of the technologies and bring back our shareholders investment returns.
Nevertheless, the company has been bothering by its former US based patent
lawyer Mr. John Rissman along with his collection agent Mr. Alan Cohen,
those who might possibly in the future proved to be wrongly using
unnecessary and inappropriate means including using fraudulent and
illegally obtained documents to treat their opponents, as their way of
business doing. Whether or not this is true, we will definitely find out.
I believe my special expertise would help me better deal with the enemies
in the market place who have been bringing turmoil to the company and
smooth whatever possible transaction. It's time for the company to prevail.
I will launch a full investigation to conduct a legitimate searching while
taking the company to positive cash flow era.
With the sufficient clinical data, we are in the position of a great
advantage and huge potential markets in Asia, Europe as well as South
America.'
About MIV Therapeutics, Inc.
MIV Therapeutics, Inc. is a development stage company in the business of
developing next-generation coatings and drug-delivery systems for
cardiovascular stents and other implantable medical devices.
Safe Harbour Statements
Except for the statements of historical fact contained herein, the
information presented in this news release constitutes 'forward-looking
statements' as such term is used in applicable United States and Canadian
laws. These statements relate to analyses and other information that are
based on forecasts of future results, estimates of amounts not yet
determinable and assumptions of management. Any statements that express or
involve discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, assumptions or future events or performance
(often, but not always, using words or phrases such as 'expects' or 'does
not expect', 'is expected', 'anticipates' or 'does not anticipate', 'plans,
'estimates' or 'intends', or stating that certain actions, events or
results 'may', 'could', 'would', 'might' or 'will' be taken, occur or be
achieved) are not statements of historical fact and should be viewed as
'forward-looking statements'. Such forward looking statements involve known
and unknown risks, uncertainties and other factors which may cause the
actual results, performance or achievements of the Company to be materially
different from any future results, performance or achievements expressed or
implied by such forward-looking statements.
Forward looking statements are made based on management's beliefs,
estimates and opinions on the date the statements are made and the Company
undertakes no obligation to update forward-looking statements if these
beliefs, estimates and opinions or other circumstances should change,
except as required by applicable law. Although the Company believes that
the beliefs, plans, expectations and intentions contained in this news
release are reasonable, there can be no assurance those beliefs, plans,
expectations or intentions will prove to be accurate. Such forward-looking
statements reflect our current views with respect to future events and are
subject to certain risks, uncertainties and assumptions, including, the
risks and uncertainties outlined in our most recent financial statements
and reports filed with the United States Securities and Exchange Commission
(the 'SEC') (available at www.sec.gov) and with Canadian securities
administrators (available at www.sedar.com). Investors should consider all
of the information set forth herein and should also refer to the risk
factors disclosed in the Company's periodic reports filed from time-to-time
with the SEC. The Company again cautions investors that the Company is not
up-to-date in its SEC or SEDAR filings. Pink OTC Markets has discontinued
the display of quotes on otcmarkets.com for the Company's securities
because the Company's securities have been labeled Caveat Emptor (Buyer
Beware) and because adequate current information has not been made
available by the Company.
This news release shall not constitute an offer to sell or the solicitation
of an offer to buy securities of the Company nor shall there be any sale of
these securities in any jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration or qualification under the
securities laws of any such jurisdiction.
End of Corporate News
---------------------------------------------------------------------
05.06.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
215046 05.06.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.06.2013 - 16:07 Uhr
Sprache: Deutsch
News-ID 266866
Anzahl Zeichen: 6302
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 186 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: MIV THERAPEUTICS INC WELCOMES ITS NEW LEADER"
steht unter der journalistisch-redaktionellen Verantwortung von
MIV Therapeutics Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
